Organs-on-Chip Technologies Laboratory, ARTORG Center, University of Bern, Bern, Switzerland.
Department of Pulmonary Medicine, University Hospital of Bern, Bern, Switzerland.
Adv Exp Med Biol. 2023;1413:191-211. doi: 10.1007/978-3-031-26625-6_10.
Since the publication of the first lung-on-a-chip in 2010, research has made tremendous progress in mimicking the cellular environment of healthy and diseased alveoli. As the first lung-on-a-chip products have recently reached the market, innovative solutions to even better mimic the alveolar barrier are paving the way for the next generation lung-on-chips. The original polymeric membranes made of PDMS are being replaced by hydrogel membranes made of proteins from the lung extracellular matrix, whose chemical and physical properties exceed those of the original membranes. Other aspects of the alveolar environment are replicated, such as the size of the alveoli, their three-dimensional structure, and their arrangement. By tuning the properties of this environment, the phenotype of alveolar cells can be tuned, and the functions of the air-blood barrier can be reproduced, allowing complex biological processes to be mimicked. Lung-on-a-chip technologies also provide the possibility of obtaining biological information that was not possible with conventional in vitro systems. Pulmonary edema leaking through a damaged alveolar barrier and barrier stiffening due to excessive accumulation of extracellular matrix proteins can now be reproduced. Provided that the challenges of this young technology are overcome, there is no doubt that many application areas will benefit greatly.
自 2010 年首个肺芯片问世以来,在模拟健康和患病肺泡的细胞环境方面已经取得了巨大的进展。随着首批肺芯片产品最近推向市场,为了更好地模拟肺泡屏障,创新性的解决方案正在为下一代肺芯片铺平道路。最初由 PDMS 制成的聚合物膜正被肺细胞外基质蛋白制成的水凝胶膜所取代,后者的化学和物理性质超过了原始膜。肺泡环境的其他方面也在被复制,例如肺泡的大小、三维结构及其排列方式。通过调整该环境的特性,可以调整肺泡细胞的表型,并再现气血屏障的功能,从而模拟复杂的生物学过程。肺芯片技术还提供了获取传统体外系统不可能获得的生物学信息的可能性。现在可以复制透过受损肺泡屏障漏出的肺水肿,以及由于细胞外基质蛋白过度积累导致的屏障僵硬。只要克服了这项年轻技术的挑战,毫无疑问,许多应用领域将受益匪浅。